Vivos therapeutics receives groundbreaking fda 510(k) clearance to treat moderate to severe pediatric sleep apnea and snoring

Vivos is poised to disrupt the very significant pediatric obstructive sleep apnea (osa) market with new fda clearance and new strategic marketing and distribution model

VVOS Ratings Summary

VVOS Quant Ranking